ArticleLife (Basel, Switzerland)2026
Kelulut Honey Modulates Skeletal Health and Bone-Related Molecular Markers in Rats Fed a High-Carbohydrate and High-Fat Diet.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHigh-carbohydrate high-fat (HCHF) diets have been associated with oxidative stress, impaired bone remodelling, and deterioration of skeletal integrity. Kelulut honey (KH), a stingless bee honey rich in antioxidant compounds, has demonstrated protective effects against bone loss; however, its effects on bone density, biomechanical properties, antioxidant status, and bone-related molecular markers remain incompletely understood. (2) Methods: Male Wistar rats were assigned to sham, negative control (NC), or KH-treated groups (200, 400, and 600 mg/kg). The NC and KH groups received an HCHF diet for 24 weeks, with KH administered during the final 12 weeks. Bone microarchitecture was evaluated using micro-computed tomography, bone mineral density (BMD) by dual-energy X-ray absorptiometry, and biomechanical properties by three-point bending. Antioxidant enzyme activities, serum bone turnover markers, and bone-related gene expression were also assessed. (3) Results: HCHF feeding reduced BMD, load, stress, Young's modulus, gluthatione peroxidase (GPx) activity, and superoxide dismutase (SOD) activity while increasing strain, displacement, serum C-terminal telopeptide of type 1 collagen (CTX-1) and receptor activator of nuclear factor-κB (RANK) levels, and runt-related transcription factor 2 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.